Roy F Chemaly

22PUBLICATIONS
112CO-AUTHORS
Major global burdens of diseaseNanomedicineMedical infection agents (incl. prions)Environmental epidemiologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 17, 2026
Efficacy and Safety of Pritelivir vs Foscarnet for the Treatment of Acyclovir-Refractory Herpes Simplex Virus Infection in Immunocompromised Adults: A Randomized, Open-Label Phase 2 Trial.

|Jul 05, 2026
Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T Cells.

|Apr 21, 2026
A decade of change: evolving epidemiology of invasive pulmonary mold infections in hematologic malignancy patients from a longitudinal infection control surveillance program.

|Mar 23, 2026
Clinical and genomic determinants associated with emergent ceftazidime-avibactam plus aztreonam non-susceptibility in ceftazidime-avibactam resistant Escherichia coli.

William C Shropshire, Jovan Borjan, Iris Y Fonseca

|Jul 30, 2025
Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis.

Hemalatha G Rangarajan, Prakash Satwani, Megan M Herr

|May 28, 2025
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR.

Kitsada Wudhikarn, Megan M Herr, Min Chen

Pageof 4

Frequent Collaborators

8 joint publications

Fareed Khawaja

5 joint publications

Miguel-Angel Perales

5 joint publications

Christopher E Dandoy

4 joint publications

Amy Spallone